{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T04:40:04Z","timestamp":1779165604709,"version":"3.51.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T00:00:00Z","timestamp":1618185600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T00:00:00Z","timestamp":1618185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100006285","name":"Magnus Bergvalls Stiftelse","doi-asserted-by":"publisher","award":["2017-02138"],"award-info":[{"award-number":["2017-02138"]}],"id":[{"id":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100006285","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100006285","name":"Magnus Bergvalls Stiftelse","doi-asserted-by":"publisher","award":["2017-02138"],"award-info":[{"award-number":["2017-02138"]}],"id":[{"id":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100006285","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100006285","name":"Magnus Bergvalls Stiftelse","doi-asserted-by":"publisher","award":["2017-02138"],"award-info":[{"award-number":["2017-02138"]}],"id":[{"id":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100006285","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s12020-021-02723-z","type":"journal-article","created":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T19:02:57Z","timestamp":1618254177000},"page":"29-37","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Rate of fracture in patients with glucocorticoid replacement therapy: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5412-6595","authenticated-orcid":false,"given":"Ling","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Bensing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Falhammar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,12]]},"reference":[{"key":"2723_CR1","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s12020-010-9359-8","volume":"38","author":"L Leelarathna","year":"2010","unstructured":"L. Leelarathna, L. Breen, J.K. Powrie, S.M. Thomas, R. Guzder, B. McGowan, P.V. Carroll, Co-morbidities, management and clinical outcome of auto-immune Addison\u2019s disease. Endocrine 38, 113\u2013117 (2010)","journal-title":"Endocrine"},{"key":"2723_CR2","doi-asserted-by":"publisher","first-page":"E2715","DOI":"10.1210\/jc.2014-2957","volume":"99","author":"H Falhammar","year":"2014","unstructured":"H. Falhammar, L. Fris\u00e9n, C. Norrby, A.L. Hirschberg, C. Almqvist, A. Nordenskj\u00f6ld, A. Nordenstr\u00f6m, Increased mortality in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 99, E2715\u2013E2721 (2014)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2723_CR3","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/j.1365-2265.2008.03340.x","volume":"69","author":"S Bensing","year":"2008","unstructured":"S. Bensing, L. Brandt, F. Tabaroj, O. Sj\u00f6berg, B. Nilsson, A. Ekbom, P. Blomqvist, O. K\u00e4mpe, Increased death risk and altered cancer incidence pattern in patients with isolated or combined autoimmune primary adrenocortical insufficiency. Clin. Endocrinol. 69, 697\u2013704 (2008)","journal-title":"Clin. Endocrinol."},{"key":"2723_CR4","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1210\/jc.2012-4059","volume":"98","author":"P Burman","year":"2013","unstructured":"P. Burman, A.F. Mattsson, G. Johannsson, C. H\u00f6ybye, H. Holmer, P. Dahlqvist, K. Berinder, B.E. Engstr\u00f6m, B. Ekman, E.M. Erfurth, J. Svensson, J. Wahlberg, F.A. Karlsson, Deaths among adult patients with hypopituitarism: hypocortisolism during acute stress, and de novo malignant brain tumors contribute to an increased mortality. J. Clin. Endocrinol. Metab. 98, 1466\u20131475 (2013)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2723_CR5","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1530\/EJE-08-0550","volume":"160","author":"MM Erichsen","year":"2009","unstructured":"M.M. Erichsen, K. L\u00f8v\u00e5s, K.J. Fougner, J. Svartberg, E.R. Hauge, J. Bollerslev, J.P. Berg, B. Mella, E.S. Husebye, Normal overall mortality rate in Addison\u2019s disease, but young patients are at risk of premature death. Eur. J. Endocrinol. 160, 233\u2013237 (2009)","journal-title":"Eur. J. Endocrinol."},{"key":"2723_CR6","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.1210\/JC.2015-2093","volume":"100","author":"H Falhammar","year":"2015","unstructured":"H. Falhammar, L. Fris\u00e9n, A.L. Hirschberg, C. Norrby, C. Almqvist, A. Nordenskj\u00f6ld, A. Nordenstr\u00f6m, Increased cardiovascular and metabolic morbidity in patients with 21-hydroxylase deficiency: a Swedish population-based national cohort study. J. Clin. Endocrinol. Metab. 100, 3520\u20133528 (2015)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2723_CR7","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1056\/NEJMra1807486","volume":"381","author":"RL Rushworth","year":"2019","unstructured":"R.L. Rushworth, D.J. Torpy, H. Falhammar, Adrenal crisis. N. Engl. J. Med 381, 852\u2013861 (2019)","journal-title":"N. Engl. J. Med"},{"key":"2723_CR8","doi-asserted-by":"publisher","first-page":"4264","DOI":"10.1210\/jc.2017-01324","volume":"102","author":"R Bergthorsdottir","year":"2017","unstructured":"R. Bergthorsdottir, O. Ragnarsson, S. Skrtic, C.A.M. Glad, S. Nilsson, I.L. Ross, M. Leonsson-Zachrisson, G. Johannsson, Visceral fat and novel biomarkers of cardiovascular disease in patients with Addison\u2019s disease: a case-control study. J. Clin. Endocrinol. Metab. 102, 4264\u20134272 (2017)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2723_CR9","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.ecl.2005.01.014","volume":"34","author":"JL Shaker","year":"2005","unstructured":"J.L. Shaker, B.P. Lukert, Osteoporosis associated with excess glucocorticoids. Endocrinol. Metab. Clin. North Am. 34, 341\u2013356 (2005). viii\u2013ix","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"2723_CR10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1530\/EJE-10-0125","volume":"163","author":"G Mazziotti","year":"2010","unstructured":"G. Mazziotti, T. Porcelli, A. Bianchi, V. Cimino, I. Patelli, C. Mejia, A. Fusco, A. Giampietro, L. De Marinis, A. Giustina, Glucocorticoid replacement therapy and vertebral fractures in hypopituitary adult males with GH deficiency. Eur. J. Endocrinol. 163, 15\u201320 (2010)","journal-title":"Eur. J. Endocrinol."},{"key":"2723_CR11","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1530\/EJE-08-0880","volume":"160","author":"K L\u00f8v\u00e5s","year":"2009","unstructured":"K. L\u00f8v\u00e5s, C.G. Gjesdal, M. Christensen, A.B. Wolff, B. Alm\u00e5s, J. Svartberg, K.J. Fougner, U. Syversen, J. Bollerslev, J.A. Falch, P.J. Hunt, V.K.K. Chatterjee, E.S. Husebye, Glucocorticoid replacement therapy and pharmacogenetics in Addison\u2019s disease: effects on bone. Eur. J. Endocrinol. 160, 993\u20131002 (2009)","journal-title":"Eur. J. Endocrinol."},{"key":"2723_CR12","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1210\/jc.2011-2036","volume":"97","author":"KR Koetz","year":"2012","unstructured":"K.R. Koetz, M. Ventz, S. Diederich, M. Quinkler, Bone mineral density is not significantly reduced in adult patients on low-dose glucocorticoid replacement therapy. J. Clin. Endocrinol. Metab. 97, 85\u201392 (2012)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2723_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0169-6009(08)80158-4","volume":"26","author":"MA Valero","year":"1994","unstructured":"M.A. Valero, M. Leon, M.P. Ruiz Valdepe\u00f1as, L. Larrodera, M.B. Lopez, K. Papapietro, A. Jara, F. Hawkins, Bone density and turnover in Addison\u2019s disease: effect of glucocorticoid treatment. Bone Min. 26, 9\u201317 (1994)","journal-title":"Bone Min."},{"key":"2723_CR14","doi-asserted-by":"publisher","first-page":"207","DOI":"10.7326\/0003-4819-120-3-199402010-00005","volume":"120","author":"PM Zelissen","year":"1994","unstructured":"P.M. Zelissen, R.J. Croughs, P.P. van Rijk, J.A. Raymakers, Effect of glucocorticoid replacement therapy on bone mineral density in patients with Addison disease. Ann. Intern. Med. 120, 207\u2013210 (1994)","journal-title":"Ann. Intern. Med."},{"key":"2723_CR15","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3389\/fendo.2020.00493","volume":"11","author":"S Rangaswamaiah","year":"2020","unstructured":"S. Rangaswamaiah, V. Gangathimmaiah, A. Nordenstrom, H. Falhammar, Bone mineral density in adults with congenital adrenal hyperplasia: a systematic review and meta-analysis. Front. Endocrinol. 11, 493 (2020)","journal-title":"Front. Endocrinol."},{"key":"2723_CR16","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1136\/ard.54.10.801","volume":"54","author":"NF Peel","year":"1995","unstructured":"N.F. Peel, D.J. Moore, N.A. Barrington, D.E. Bax, R. Eastell, Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis. Ann. Rheum. Dis. 54, 801\u2013806 (1995)","journal-title":"Ann. Rheum. Dis."},{"key":"2723_CR17","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s001980200108","volume":"13","author":"TP van Staa","year":"2002","unstructured":"T.P. van Staa, H.G.M. Leufkens, C. Cooper, The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos. Int. 13, 777\u2013787 (2002)","journal-title":"Osteoporos. Int."},{"key":"2723_CR18","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1210\/jc.2018-01865","volume":"103","author":"PW Speiser","year":"2018","unstructured":"P.W. Speiser, W. Arlt, R.J. Auchus, L.S. Baskin, G.S. Conway, D.P. Merke, H.F.L. Meyer-Bahlburg, W.L. Miller, M.H. Murad, S.E. Oberfield, P.C. White, Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 103, 4043\u20134088 (2018)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2723_CR19","doi-asserted-by":"publisher","first-page":"4643","DOI":"10.1210\/jc.2007-0744","volume":"92","author":"H Falhammar","year":"2007","unstructured":"H. Falhammar, H. Filipsson, G. Holmdahl, P.-O. Janson, A. Nordenskj\u00f6ld, K. Hagenfeldt, M. Thor\u00e9n, Fractures and bone mineral density in adult women with 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 92, 4643\u20134649 (2007)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2723_CR20","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1530\/EJE-16-0104","volume":"175","author":"F Ceccato","year":"2016","unstructured":"F. Ceccato, M. Barbot, N. Albiger, M. Zilio, P. De Toni, G. Luisetto, M. Zaninotto, N.A. Greggio, M. Boscaro, C. Scaroni, V. Camozzi, Long-term glucocorticoid effect on bone mineral density in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Eur. J. Endocrinol. 175, 101\u2013106 (2016)","journal-title":"Eur. J. Endocrinol."},{"key":"2723_CR21","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1210\/jc.2015-1710","volume":"101","author":"SR Bornstein","year":"2016","unstructured":"S.R. Bornstein, B. Allolio, W. Arlt, A. Barthel, A. Don-Wauchope, G.D. Hammer, E.S. Husebye, D.P. Merke, M.H. Murad, C.A. Stratakis, D.J. Torpy, Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 101, 364\u2013389 (2016)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2723_CR22","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.1210\/jc.2016-2118","volume":"101","author":"M Fleseriu","year":"2016","unstructured":"M. Fleseriu, I.A. Hashim, N. Karavitaki, S. Melmed, M.H. Murad, R. Salvatori, M.H. Samuels, Hormonal replacement in hypopituitarism in adults: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 101, 3888\u20133921 (2016)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2723_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000100","volume":"6","author":"A Liberati","year":"2009","unstructured":"A. Liberati, D.G. Altman, J. Tetzlaff, C. Mulrow, P.C. G\u00f8tzsche, J.P.A. Ioannidis, M. Clarke, P.J. Devereaux, J. Kleijnen, D. Moher, The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 6, e1000100 (2009)","journal-title":"PLoS Med."},{"key":"2723_CR24","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1530\/EC-18-0160","volume":"7","author":"KR Frey","year":"2018","unstructured":"K.R. Frey, T. Kienitz, J. Schulz, M. Ventz, K. Zopf, M. Quinkler, Prednisolone is associated with a worse bone mineral density in primary adrenal insufficiency. Endocr. Connect. 7, 811\u2013818 (2018)","journal-title":"Endocr. Connect."},{"key":"2723_CR25","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1530\/eje.0.1370240","volume":"137","author":"T Ros\u00e9n","year":"1997","unstructured":"T. Ros\u00e9n, L. Wilhelmsen, K. Landin-Wilhelmsen, G. Lappas, B.A. Bengtsson, Increased fracture frequency in adult patients with hypopituitarism and GH deficiency. Eur. J. Endocrinol. 137, 240\u2013245 (1997)","journal-title":"Eur. J. Endocrinol."},{"key":"2723_CR26","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1530\/EJE-12-0865","volume":"168","author":"H Falhammar","year":"2013","unstructured":"H. Falhammar, H. Filipsson Nystr\u00f6m, A. Wedell, K. Brismar, M. Thor\u00e9n, Bone mineral density, bone markers, and fractures in adult males with congenital adrenal hyperplasia. Eur. J. Endocrinol. 168, 331\u2013341 (2013)","journal-title":"Eur. J. Endocrinol."},{"key":"2723_CR27","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1530\/EC-18-0031","volume":"7","author":"H Falhammar","year":"2018","unstructured":"H. Falhammar, H. Claahsen-van der Grinten, N. Reisch, J. Slowikowska-Hilczer, A. Nordenstr\u00f6m, R. Roehle, C. Bouvattier, B.P.C. Kreukels, B. K\u00f6hler; dsd-LIFE group, Health status in 1040 adults with disorders of sex development (DSD): a European multicenter study. Endocr. Connect 7, 466\u2013478 (2018)","journal-title":"Endocr. Connect"},{"key":"2723_CR28","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1530\/EJE-07-0887","volume":"158","author":"Z Chakhtoura","year":"2008","unstructured":"Z. Chakhtoura, A. Bachelot, D. Samara-Boustani, J.-C. Ruiz, B. Donadille, J. Dulon, S. Christin-Ma\u00eetre, C. Bouvattier, M.-C. Raux-Demay, P. Bouchard, J.-C. Carel, J. Leger, F. Kuttenn, M. Polak, P. Touraine, Centre des maladies endocriniennes rares de la croissance and association surr\u00e9nales, impact of total cumulative glucocorticoid dose on bone mineral density in patients with 21-hydroxylase deficiency. Eur. J. Endocrinol. 158, 879\u2013887 (2008)","journal-title":"Eur. J. Endocrinol."},{"key":"2723_CR29","first-page":"62","volume":"20","author":"N Raizada","year":"2016","unstructured":"N. Raizada, V.P. Jyotsna, A.D. Upadhyay, N. Gupta, Bone mineral density in young adult women with congenital adrenal hyperplasia, Indian. J. Endocrinol. Metab. 20, 62\u201366 (2016)","journal-title":"J. Endocrinol. Metab."},{"key":"2723_CR30","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/cen.12507","volume":"82","author":"D El-Maouche","year":"2015","unstructured":"D. El-Maouche, S. Collier, M. Prasad, J.C. Reynolds, D.P. Merke, Cortical bone mineral density in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Clin. Endocrinol. 82, 330\u2013337 (2015)","journal-title":"Clin. Endocrinol."},{"key":"2723_CR31","doi-asserted-by":"publisher","first-page":"105734","DOI":"10.1016\/j.jsbmb.2020.105734","volume":"204","author":"MK Auer","year":"2020","unstructured":"M.K. Auer, L. Paizoni, L.C. Hofbauer, M. Rauner, Y. Chen, H. Schmidt, A. Huebner, M. Bidlingmaier, N. Reisch, Effects of androgen excess and glucocorticoid exposure on bone health in adult patients with 21-hydroxylase deficiency. J. Steroid Biochem. Mol. Biol. 204, 105734 (2020). https:\/\/doi.org\/10.1016\/j.jsbmb.2020.105734","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"2723_CR32","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/cen.14149","volume":"92","author":"G Riehl","year":"2020","unstructured":"G. Riehl, N. Reisch, R. Roehle, H. Claahsen van der Grinten, H. Falhammar, M. Quinkler, Bone mineral density and fractures in congenital adrenal hyperplasia: findings from the dsd-LIFE study. Clin. Endocrinol. 92, 284\u2013294 (2020)","journal-title":"Clin. Endocrinol."},{"key":"2723_CR33","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s00223-008-9124-7","volume":"82","author":"P Vestergaard","year":"2008","unstructured":"P. Vestergaard, L. Rejnmark, L. Mosekilde, Fracture risk associated with different types of oral corticosteroids and effect of termination of corticosteroids on the risk of fractures. Calcif. Tissue Int. 82, 249\u2013257 (2008)","journal-title":"Calcif. Tissue Int."},{"key":"2723_CR34","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.1365-2796.2011.02352.x","volume":"270","author":"S Bj\u00f6rnsdottir","year":"2011","unstructured":"S. Bj\u00f6rnsdottir, M. S\u00e4\u00e4f, S. Bensing, O. K\u00e4mpe, K. Micha\u00eblsson, J.F. Ludvigsson, Risk of hip fracture in Addison\u2019s disease: a population-based cohort study. J. Intern. Med. 270, 187\u2013195 (2011)","journal-title":"J. Intern. Med."},{"key":"2723_CR35","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s12020-017-1380-8","volume":"59","author":"V Camozzi","year":"2018","unstructured":"V. Camozzi, C. Betterle, A.C. Frigo, V. Zaccariotto, M. Zaninotto, E. De Caneva, P. Lucato, W. Gomiero, S. Garelli, C. Sabbadin, M. Salv\u00e0, M.D. Costa, M. Boscaro, G. Luisetto, Vertebral fractures assessed with dual-energy X-ray absorptiometry in patients with Addison\u2019s disease on glucocorticoid and mineralocorticoid replacement therapy. Endocrine 59, 319\u2013329 (2018)","journal-title":"Endocrine"},{"key":"2723_CR36","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1007\/BF03347471","volume":"27","author":"V Camozzi","year":"2004","unstructured":"V. Camozzi, V. Carraro, M. Zangari, F. Fallo, F. Mantero, G. Luisetto, Use of quantitative ultrasound of the hand phalanges in the diagnosis of two different osteoporotic syndromes: Cushing\u2019s syndrome and postmenopausal osteoporosis. J. Endocrinol. Investig. 27, 510\u2013515 (2004)","journal-title":"J. Endocrinol. Investig."},{"key":"2723_CR37","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s12020-015-0738-z","volume":"52","author":"G Mazziotti","year":"2016","unstructured":"G. Mazziotti, M. Doga, S. Frara, F. Maffezzoni, T. Porcelli, L. Cerri, R. Maroldi, A. Giustina, Incidence of morphometric vertebral fractures in adult patients with growth hormone deficiency. Endocrine 52, 103\u2013110 (2016)","journal-title":"Endocrine"},{"key":"2723_CR38","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1210\/jc.2006-1350","volume":"92","author":"H Falhammar","year":"2007","unstructured":"H. Falhammar, H. Filipsson, G. Holmdahl, P.-O. Janson, A. Nordenskj\u00f6ld, K. Hagenfeldt, M. Thor\u00e9n, Metabolic profile and body composition in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 92, 110\u2013116 (2007)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2723_CR39","doi-asserted-by":"publisher","unstructured":"A. Nordenstr\u00f6m, H. Falhammar, Management of endocrine disease: diagnosis and management of the patient with non-classic CAH due to 21-hydroxylase deficiency, Eur. J. Endocrinol. R127\u2013R145 (2019). https:\/\/doi.org\/10.1530\/eje-18-0712.","DOI":"10.1530\/eje-18-0712"},{"key":"2723_CR40","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1210\/js.2019-00136","volume":"3","author":"E Whittle","year":"2019","unstructured":"E. Whittle, H. Falhammar, Glucocorticoid regimens in the treatment of congenital adrenal hyperplasia: a systematic review and meta-analysis. J. Endocr. Soc. 3, 1227\u20131245 (2019)","journal-title":"J. Endocr. Soc."},{"key":"2723_CR41","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s12020-011-9591-x","volume":"41","author":"H Falhammar","year":"2012","unstructured":"H. Falhammar, M. Thor\u00e9n, Clinical outcomes in the management of congenital adrenal hyperplasia. Endocrine 41, 355\u2013373 (2012)","journal-title":"Endocrine"},{"key":"2723_CR42","doi-asserted-by":"publisher","first-page":"3432","DOI":"10.1210\/jc.2009-0636","volume":"94","author":"L Frisen","year":"2009","unstructured":"L. Frisen, A. Nordenstrom, H. Falhammar, H. Filipsson, G. Holmdahl, P.O. Janson, M. Thoren, K. Hagenfeldt, A. Moller, A. Nordenskjold, Gender role behavior, sexuality, and psychosocial adaptation in women with congenital adrenal hyperplasia due to CYP21A2 deficiency. J. Clin. Endocrinol. Metab. 94, 3432\u20133439 (2009)","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-021-02723-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-021-02723-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-021-02723-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T21:05:48Z","timestamp":1631653548000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-021-02723-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,12]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["2723"],"URL":"https:\/\/doi.org\/10.1007\/s12020-021-02723-z","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,12]]},"assertion":[{"value":"4 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"L.L. declares that she has no conflict of interest. S.B. declares that she has no conflict of interest. H.F. declares that he has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}